Search Results - "Jensen, P. E. H." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

by Rup, B., Pallardy, M., Sikkema, D., Albert, T., Allez, M., Broet, P., Carini, C., Creeke, P., Davidson, J., De Vries, N., Finco, D., Fogdell‐Hahn, A., Havrdova, E., Hincelin‐Mery, A., C. Holland, M., H. Jensen, P. E., Jury, E. C., Kirby, H., Kramer, D., Lacroix‐Desmazes, S., Legrand, J., Maggi, E., Maillère, B., Mariette, X., Mauri, C., Mikol, V., Mulleman, D., Oldenburg, J., Paintaud, G., R. Pedersen, C., Ruperto, N., Seitz, R., Spindeldreher, S., Deisenhammer, F.
Published in Clinical and experimental immunology (01.09.2015)

Get full text

Journal Article

Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009

Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009

by Pedersen, E. G., Hallas, J., Hansen, K., Jensen, P. E. H., Gaist, D.
Published in European journal of neurology (01.02.2013)

Get full text

Journal Article

Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark

Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark

by Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H., Gaist, D.
Published in European journal of neurology (01.06.2013)

Get full text

Journal Article

Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

by Ravnborg, M, Bendtzen, K, Christensen, O, Jensen, PEH, Hesse, D, Tovey, MG, Sørensen, PS
Published in Multiple sclerosis (01.03.2009)

Get full text

Journal Article

Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine

Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine

by Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H., Gaist, D.
Published in European journal of neurology (01.03.2014)

Get full text

Journal Article

NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis

NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis

by Ammitzbøll, C., Dyrby, T.B., Börnsen, L., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Lundell, H., Jensen, P.E.H., Sørensen, P.S., Siebner, H.R., Sellebjerg, F.
Published in Multiple sclerosis and related disorders (01.09.2023)

Get full text

Journal Article

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study

by Oturai, A. B., Koch-Henriksen, N., Petersen, T., Jensen, P. E. H., Sellebjerg, F., Sorensen, P. S.
Published in European journal of neurology (01.03.2009)

Get full text

Journal Article

Identification of new sensitive biomarkers for the in vivo response to interferon-β treatment in multiple sclerosis using DNA-array evaluation

Identification of new sensitive biomarkers for the in vivo response to interferon-β treatment in multiple sclerosis using DNA-array evaluation

by Sellebjerg, F., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A., Soelberg Sørensen, P.
Published in European journal of neurology (01.12.2009)

Get full text

Journal Article

Myasthenia and risk of cancer: a population-based case-control study

Myasthenia and risk of cancer: a population-based case-control study

by Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H., Gaist, D.
Published in European journal of neurology (01.05.2014)

Get full text

Journal Article

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

by Jensen, P. E. H., Sellebjerg, F., Søndergaard, H. B., Sørensen, P. S.
Published in European journal of neurology (01.10.2012)

Get full text

Journal Article

Native and transformed α2-macroglobulin in plasma from patients with multiple sclerosis

Native and transformed α2-macroglobulin in plasma from patients with multiple sclerosis

by Gunnarsson, M., Sundström, P., Stigbrand, T., Jensen, P. E. H.
Published in Acta neurologica Scandinavica (01.07.2003)

Get full text

Journal Article

Immunochemical aberrations of α2‐macroglobulin purified from a patient with multiple sclerosis

Immunochemical aberrations of α2‐macroglobulin purified from a patient with multiple sclerosis

by Gunnarsson, M., Stigbrand, T., Jensen, P. E. H.
Published in Acta neurologica Scandinavica (01.12.2000)

Get full text

Journal Article

Late‐onset myasthenia not on the increase: a nationwide register study in D enmark, 1996–2009

Late‐onset myasthenia not on the increase: a nationwide register study in D enmark, 1996–2009

by Pedersen, E. G., Hallas, J., Hansen, K., Jensen, P. E. H., Gaist, D.
Published in European journal of neurology (01.02.2013)

Get full text

Journal Article

Correlation between anti-interferon-[beta] binding and neutralizing antibodies in interferon-[beta]-treated multiple sclerosis patients

Correlation between anti-interferon-[beta] binding and neutralizing antibodies in interferon-[beta]-treated multiple sclerosis patients

by Jensen, P. E. H, Sellebjerg, F, Søndergaard, H. B, Sørensen, P. S
Published in European journal of neurology (01.10.2012)

Get full text

Journal Article

Use of azathioprine for non‐thymoma myasthenia and risk of cancer: a nationwide case–control study in D enmark

Use of azathioprine for non‐thymoma myasthenia and risk of cancer: a nationwide case–control study in D enmark

by Pedersen, E. G., Pottegård, A., Hallas, J., Friis, S., Hansen, K., Jensen, P. E. H., Gaist, D.
Published in European journal of neurology (01.06.2013)

Get full text

Journal Article

Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis

Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis

by Petersen, ER, Søndergaard, HB, Oturai, AB, Jensen, PEH, Sorensen, PS, Sellebjerg, F, Börnsen, L
Published in Multiple sclerosis and related disorders (01.11.2016)

Get full text

Journal Article

Native and transformed alpha2-macroglobulin in plasma from patients with multiple sclerosis

Native and transformed alpha2-macroglobulin in plasma from patients with multiple sclerosis

by Gunnarsson, M, Sundström, P, Stigbrand, T, Jensen, P E H
Published in Acta neurologica Scandinavica (01.07.2003)

Get full text

Journal Article

Native and transformed α 2 -macroglobulin in plasma from patients with multiple sclerosis: α 2 -Macroglobulin and multiple sclerosis

Native and transformed α 2 -macroglobulin in plasma from patients with multiple sclerosis: α 2 -Macroglobulin and multiple sclerosis

by Gunnarsson, M., Sundström, P., Stigbrand, T., Jensen, P. E. H.
Published in Acta neurologica Scandinavica (01.07.2003)

Get full text

Journal Article

Immunochemical aberrations of α 2 -macroglobulin purified from a patient with multiple sclerosis: α 2 -macroglobulin and multiple sclerosis

Immunochemical aberrations of α 2 -macroglobulin purified from a patient with multiple sclerosis: α 2 -macroglobulin and multiple sclerosis

by Gunnarsson, M., Stigbrand, T., Jensen, P. E. H.
Published in Acta neurologica Scandinavica (01.12.2000)

Get full text

Journal Article

Aberrant forms of α2-macroglobulin purified from patients with multiple sclerosis

Aberrant forms of α2-macroglobulin purified from patients with multiple sclerosis

by GUNNARSSON, M, STIGBRAND, T, JENSEN, P. E. H
Published in Clinica chimica acta (01.05.2000)

Get full text

Journal Article